Correspondence 0001493152-23-033507 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)

Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 22, 2023 · CIK: 0001922335 · Accession: 0001493152-23-033507

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-271622

Date

Sept. 22, 2023

Author

Chief

Form

CORRESP

Company

Syra Health Corp (SYRA) (CIK 0001922335)

Letter

SYRA HEALTH CORP.

Keystone Way N. #201

Carmel, IN 46032

September 22, 2023

VIA EDGAR

United States Securities and Exchange Commission

F. Street, NE

Washington, DC 20549

Attn: Scott Stringer

Joel Parker

Brian Fetterolf

Erin Jaskot

Re: Syra Health Corp.

Registration Statement on Form S-1, as amended

File No. 333-271622

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Syra Health Corp. (the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 26, 2023, or as soon thereafter as possible.

Please notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.

Thank you,

SYRA HEALTH CORP.

By: /s/ Deepika Vuppalanchi

Name: Deepika Vuppalanchi

Title: Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

SYRA
HEALTH CORP.

1119
Keystone Way N. #201

Carmel,
IN 46032

September
22, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

100
F. Street, NE

Washington,
DC 20549

    Attn:
    Scott
    Stringer

    Joel
    Parker

    Brian
    Fetterolf

    Erin
    Jaskot

    Re:
    Syra
    Health Corp.

    Registration
    Statement on Form S-1, as amended

    File
    No. 333-271622

Ladies
and Gentlemen:

Pursuant
to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), Syra Health Corp.
(the “Company”) respectfully requests that the effective date of the registration statement referred to above be accelerated
so that it will become effective at 4:30 p.m., Eastern Time, on Tuesday, September 26, 2023, or as soon thereafter as possible.

Please
notify Nazia Khan of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (202) 747-2651 as soon as possible as to
the time the Registration Statement has been declared effective pursuant to this acceleration request.

    Thank you,

    SYRA HEALTH CORP.

    By:
    /s/
    Deepika Vuppalanchi

    Name:
    Deepika
    Vuppalanchi

    Title:
    Chief
    Executive Officer

SecProbe.io